Rebolj, Matejka http://orcid.org/0000-0001-9597-645X
Brentnall, Adam R.
Cuschieri, Kate http://orcid.org/0000-0002-2604-3928
Funding for this research was provided by:
Cancer Research UK (C8162/A27047)
Article History
Received: 11 December 2023
Revised: 2 April 2024
Accepted: 3 April 2024
First Online: 13 April 2024
Competing interests
: MR: The former Public Health England (now: NHS England and Department of Health/Office for Health Improvement and Disparities) provided funding for the epidemiological evaluation of various cervical screening studies; current and former members of various expert groups provided advice to the English Cervical Screening Programme; attended meetings with HPV test manufacturers; fees for attendance at advisory board and other meetings organised by Hologic, shared with the employer, including travel cost reimbursement if applicable. ARB: Member of the UK National Screening Committee Research and Methodology subgroup. KC: Research funding or consumables to support research in the last three years from Cepheid, Euroimmun, GeneFirst, SelfScreen, Hiantis Seegene, Roche, Abbott, Hologic, and Daye, paid to the employer. Professional Clinical Advisor to the English Cervical Screening Programme; member of various expert groups providing advice to the Scottish and English Cervical Screening Programme; UK travel reimbursement for attendance at the advisory board meeting by Hologic.
: Not required.
: Not required.